OR
Last reporting period 31 Dec, 2022
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.005
Exchange
XCSE - Nasdaq Copenhagen A/S
—
Last period Current ratio
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Orphazyme
Company Analysis
ORPHA.CO valuation, rating, competitors, insights and company profile
Eyestock Rating
ORPHA.CO financial analysis by Eyestock methodology
Valuation
ORPHA.CO valuation using historical relative method
Statements
ORPHA.CO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
ORPHA.CO dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
